Report error Found 3364 with Last Name = 'stamford' and Initial = 'aw'
Affinity DataEC50: 42nMAssay Description:Agonist activity at mouse GPR119 assessed as increase in cAMP levelMore data for this Ligand-Target Pair
Affinity DataEC50: 75nMAssay Description:Agonist activity at mouse GPR119 assessed as increase in cAMP levelMore data for this Ligand-Target Pair
Affinity DataEC50: 25nMAssay Description:Agonist activity at mouse GPR119 assessed as increase in cAMP levelMore data for this Ligand-Target Pair
Affinity DataEC50: 312nMAssay Description:Agonist activity at mouse GPR119 assessed as increase in cAMP levelMore data for this Ligand-Target Pair
Affinity DataEC50: 516nMAssay Description:Agonist activity at mouse GPR119 assessed as increase in cAMP levelMore data for this Ligand-Target Pair
Affinity DataEC50: 60nMAssay Description:Agonist activity at mouse GPR119 assessed as increase in cAMP levelMore data for this Ligand-Target Pair
Affinity DataEC50: 278nMAssay Description:Agonist activity at mouse GPR119 assessed as increase in cAMP levelMore data for this Ligand-Target Pair
Affinity DataKd: 160nMAssay Description:Binding affinity to ENL YEATS domain (unknown origin) at 100 uM by ITC analysisMore data for this Ligand-Target Pair
Ligand InfoSimilars
Affinity DataEC50: 17nMAssay Description:Agonist activity at human GPR119 expressed in HEK293 cells assessed as increase in cAMP level after 30 mins by LANCE assayMore data for this Ligand-Target Pair
Affinity DataEC50: 188nMAssay Description:Agonist activity at human GPR119 expressed in HEK293 cells assessed as increase in cAMP level after 30 mins by LANCE assayMore data for this Ligand-Target Pair
Affinity DataEC50: 43nMAssay Description:Agonist activity at mouse GPR119 assessed as increase in cAMP levelMore data for this Ligand-Target Pair
Affinity DataKd: 120nMAssay Description:Binding affinity to ENL YEATS domain (unknown origin) at 100 uM by ITC analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 5.10nMAssay Description:Agonist activity at human GPR119 expressed in HEK293 cells assessed as increase in cAMP level after 30 mins by LANCE assayMore data for this Ligand-Target Pair
Affinity DataEC50: 13nMAssay Description:Agonist activity at human GPR119 expressed in HEK293 cells assessed as increase in cAMP level after 30 mins by LANCE assayMore data for this Ligand-Target Pair
Affinity DataEC50: 10nMAssay Description:Agonist activity at human GPR119 expressed in HEK293 cells assessed as increase in cAMP level after 30 mins by LANCE assayMore data for this Ligand-Target Pair
Affinity DataEC50: 21nMAssay Description:Agonist activity at mouse GPR119 assessed as increase in cAMP levelMore data for this Ligand-Target Pair
Affinity DataEC50: 2.60nMAssay Description:Agonist activity at human GPR119 expressed in HEK293 cells assessed as increase in cAMP level after 30 mins by LANCE assayMore data for this Ligand-Target Pair
Affinity DataEC50: 58nMAssay Description:Agonist activity at mouse GPR119 assessed as increase in cAMP levelMore data for this Ligand-Target Pair
Affinity DataEC50: 49nMAssay Description:Agonist activity at human GPR119 expressed in HEK293 cells assessed as increase in cAMP level after 30 mins by LANCE assayMore data for this Ligand-Target Pair
Affinity DataEC50: 113nMAssay Description:Agonist activity at mouse GPR119 assessed as increase in cAMP levelMore data for this Ligand-Target Pair
Affinity DataEC50: 67nMAssay Description:Agonist activity at mouse GPR119 assessed as increase in cAMP levelMore data for this Ligand-Target Pair
Affinity DataEC50: 58nMAssay Description:Agonist activity at mouse GPR119 assessed as increase in cAMP levelMore data for this Ligand-Target Pair
Affinity DataKd: 3.20E+4nMAssay Description:Binding affinity to BACE1 by fragment-based NMR screening assayMore data for this Ligand-Target Pair
Affinity DataEC50: 10nMAssay Description:Agonist activity at human GPR119 expressed in HEK293 cells assessed as increase in cAMP level after 30 mins by LANCE assayMore data for this Ligand-Target Pair
Affinity DataEC50: 248nMAssay Description:Agonist activity at mouse GPR119 assessed as increase in cAMP levelMore data for this Ligand-Target Pair
Affinity DataEC50: 8nMAssay Description:Agonist activity at human GPR119 expressed in HEK293 cells assessed as increase in cAMP level after 30 mins by LANCE assayMore data for this Ligand-Target Pair
Affinity DataEC50: 44nMAssay Description:Agonist activity at mouse GPR119 assessed as increase in cAMP levelMore data for this Ligand-Target Pair
Affinity DataEC50: 10nMAssay Description:Agonist activity at human GPR119 expressed in HEK293 cells assessed as increase in cAMP level after 30 mins by LANCE assayMore data for this Ligand-Target Pair
Affinity DataEC50: 19nMAssay Description:Agonist activity at human GPR119 expressed in HEK293 cells assessed as increase in cAMP level after 30 mins by LANCE assayMore data for this Ligand-Target Pair
Affinity DataEC50: 3.5nMAssay Description:Agonist activity at human GPR119 expressed in HEK293 cells assessed as increase in cAMP level after 30 mins by LANCE assayMore data for this Ligand-Target Pair
Affinity DataKd: 100nMAssay Description:Binding affinity to ENL YEATS domain (unknown origin) at 100 uM by ITC analysisMore data for this Ligand-Target Pair
Affinity DataEC50: 6nMAssay Description:Agonist activity at human GPR119 expressed in HEK293 cells assessed as increase in cAMP level after 30 mins by LANCE assayMore data for this Ligand-Target Pair
Affinity DataEC50: 26nMAssay Description:Agonist activity at human GPR119 expressed in HEK293 cells assessed as increase in cAMP level after 30 mins by LANCE assayMore data for this Ligand-Target Pair
Affinity DataKd: 5.50E+5nMAssay Description:Binding affinity to BACE1 by fragment-based NMR screening assayMore data for this Ligand-Target Pair
Affinity DataEC50: 212nMAssay Description:Agonist activity at human GPR119 expressed in HEK293 cells assessed as increase in cAMP level after 30 mins by LANCE assayMore data for this Ligand-Target Pair
Affinity DataEC50: 97nMAssay Description:Agonist activity at human GPR119 expressed in HEK293 cells assessed as increase in cAMP level after 30 mins by LANCE assayMore data for this Ligand-Target Pair
Affinity DataEC50: 6nMAssay Description:Agonist activity at human GPR119 expressed in HEK293 cells assessed as increase in cAMP level after 30 mins by LANCE assayMore data for this Ligand-Target Pair
Affinity DataEC50: 15nMAssay Description:Agonist activity at human GPR119 expressed in HEK293 cells assessed as increase in cAMP level after 30 mins by LANCE assayMore data for this Ligand-Target Pair
Affinity DataEC50: 60nMAssay Description:Agonist activity at mouse GPR119 assessed as increase in cAMP levelMore data for this Ligand-Target Pair
Affinity DataEC50: 0.427nMAssay Description:Agonist activity at mouse GPR119 assessed as increase in cAMP levelMore data for this Ligand-Target Pair
Affinity DataKd: 1.50E+4nMAssay Description:Binding affinity to BACE1 by fragment-based NMR screening assayMore data for this Ligand-Target Pair
Affinity DataEC50: 46nMAssay Description:Agonist activity at mouse GPR119 assessed as increase in cAMP levelMore data for this Ligand-Target Pair
Affinity DataIC50: 0.0120nMAssay Description:Inhibition of HIV1 protease expressed in Escherichia coli using Val-Ser-Gln-Asn-(beta-naphtyl)Ala-Pro-Ile-Val as substrate preincubated for 30 mins f...More data for this Ligand-Target Pair
Affinity DataIC50: 0.0130nMAssay Description:Inhibition of HIV1 protease expressed in Escherichia coli using Val-Ser-Gln-Asn-(beta-naphtyl)Ala-Pro-Ile-Val as substrate preincubated for 30 mins f...More data for this Ligand-Target Pair
Affinity DataIC50: 0.0400nMAssay Description:Inhibition of HIV1 protease expressed in Escherichia coli using Val-Ser-Gln-Asn-(beta-naphtyl)Ala-Pro-Ile-Val as substrate preincubated for 30 mins f...More data for this Ligand-Target Pair
Affinity DataIC50: 0.152nMAssay Description:3x Complete Substrate plus Inhibitor Solution in Assay Medium (Opti-MEM I Reduced Serum Medium, no phenol red, and no serum) was prepared just before...More data for this Ligand-Target Pair
Affinity DataIC50: 0.152nMAssay Description:3x Complete Substrate plus Inhibitor Solution in Assay Medium (Opti-MEM I Reduced Serum Medium, no phenol red, and no serum) was prepared just before...More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Schering-Plough Research Institute
Curated by ChEMBL
Schering-Plough Research Institute
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of human phosphodiesterase 5More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Schering-Plough Research Institute
Curated by ChEMBL
Schering-Plough Research Institute
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Concentration required to inhibit phosphodiesterase type 5 (PDE5) isolated from corpus cavernosum by 50% was determinedMore data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
Schering-Plough Research Institute
Curated by ChEMBL
Schering-Plough Research Institute
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibitory concentration against human phosphodiesterase 5 (PDE5) enzymeMore data for this Ligand-Target Pair































